News
Avoid extreme restriction: Severe calorie restriction can lead to binge-restrict cycles, metabolic adaptation and hormonal ...
Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from ...
A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA approval is expected in 2026.
People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.
GLP-1s can result in quick weight loss, but it’s important to understand they are no quick fix or magic bullet. If you don’t develop long-term healthy habits, the weight is likely to return ...
Tirzepatide is more effective than semaglutide for weight loss, according to a new study on GLP-1 medications The study was funded by Eli Lilly, the pharmaceutical company that manufactures ...
Weight loss drugs might shrink your waistline — but they could also wreck your smile. GLP-1 users have reported a mouthful of problems, including dry mouth, bad breath, gum disease and tooth decay.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results